According to the current analysis of Reports and Data, the global Urinalysis Market was valued at USD 3.40 billion in 2021 and is expected to reach USD 6.34 billion by the year 2030, at a CAGR of 7.1%. Urinalysis can provide doctors and physicians with valuable information about patient’s health status, including indications of renal, urological and liver disease, diabetes mellitus, urinary tract infection (UTI) and general hydration. Urinalysis can be used to screen for substances that would not usually be expected to be present in urine, for example, glucose, leucocytes, nitrite and blood. If these substances are present, further analysis of urine and/or blood may be required. Although urinalysis is an effective screening tool, it should not be used in isolation to guide treatment because false positives, for example, nitrites, and false negatives, for example, glucose, can occur if the sample is contaminated or left to stand for too long. Urinalysis is an effective screening tool that can be used to detect systemic diseases and infections. There are a variety of methods of collecting urine specimens and it is essential to ensure that contamination is limited to reduce the potential for inaccurate results. Reagent strips are a quick and easy method for testing urine and can provide valuable information about a patient’s condition.
Get a sample copy of the global Urinalysis market report @ https://www.reportsanddata.com/download-free-sample/2229
The global pharma healthcare market revenue growth is majorly driven by factors such as rising prevalence of chronic and acute diseases globally, rise in global geriatric population, growing awareness of health wellness among consumers, and growing demand for advanced medications and therapeutics. Growing need for advanced, patient-centered healthcare services, increasing availability of advanced point-of-care diagnostics, increasing biotechnological and pharmaceutical research development activities and clinical trials, and rise in public and private investments in the healthcare industry are some of the other major factors supporting market revenue growth. Market revenue growth is further driven by factors such as rising cases of the novel coronavirus disease, rising focus on development of rapid COVID-19 diagnostics including the RT-PCR test kits, increasing government intiatives towards manufacturing and distribution of COVID-19 vaccines, rising trends of telehealth and telemedicine, and growing need for remote patient care monitoring solutions.
Further key findings from the report suggest
- Fully automated urine strip readers and automated urine sediment analyzers which includes UriSed mini and UriSed 2 from 77 Elektronika Kft represent the technologically advanced instruments available in the market
- The large number target population and the observed high, unmet clinical needs in under-developed regions provide the market with a large pool of opportunities for potential growth
- In 2019, DIRUI Industrial Co. Ltd. launched the FUS 1000 Automated Urine Analyzer.
- Automated and semi-automated biochemical urine analyzers, urine sediment analyzers, and microscopic urine analyzers are the widely used instruments in the urinalysis market
- The rising prevalence of target diseases including diabetes, kidney diseases, and Urinary Tract Infections and the introduction of technologically advanced, rapid, non-invasive, and user-friendly tools for urinalysis are expected to drive growth of this market
- North America is dominating the market, with the highest market share of 30.7% in 2019. The U.S. contributed the largest revenue share to the North American as well as global urinalysis market
- The Sediment urinalysis segment is expected to show significant CAGR during the forecast period
Leading Players in the Global Pharma Healthcare Market:
Hoffmann-LA Roche AG, Danaher Corporation, Siemens AG, Sysmex Corporation, Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Acon Laboratories, Inc., Arkray, Inc. and United Medical Electronic Group Co., Ltd.
Regional Outlook of the Global Urinalysis Market:
Under this section of the report, the authors comprehensively analyze the key regional markets in the global Urinalysis market. This section accurately evaluates the revenue shares and year-on-year revenue growth rate of these regional markets. Key regional markets encompassed in the report include North America, Europe, Asia Pacific, Latin America, and the Middle East Africa.
Application Outlook (Revenue, USD Billion; 2019–2030)
- Urinary Tract Infection (UTI)
- Kidney Disease
- Pregnancy and Fertility
- Diabetes
- Others
Product Type Outlook (Revenue, USD Billion; 2019–2030)
- Consumables
- Instruments
End-use Outlook (Revenue, USD Billion; 2019–2030)
- Hospitals and Clinics
- Academic Research Laboratories
- Diagnostic Laboratories
Detailed Regional Market Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East Africa)
Key points covered in the global Urinalysis market report:
- The report presents a detailed study of the global Urinalysis market
- It specializes in the study of the major market dynamics including driving and restraining market growth, latest product trends, and latest technological advancements
- The report offers detailed market segmentation based on product type, application spectrum, and end-use landscape, and distribution channel
- It focuses on the latest product developments and company profiles of the market’s leading players
Request a customized copy of the Urinalysis market report @ https://www.reportsanddata.com/request-customization-form/2229
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
Get Explore Latest Research Report by Reports and Data:
About Reports and Data
Silver Wound Dressings Market @ https://www.reportsanddata.com/report-detail/silver-wound-dressings-market
Rheumatoid Arthritis Drugs Market @ https://www.reportsanddata.com/report-detail/rheumatoid-arthritis-drugs-market
Tissue Diagnostics Market @ https://www.reportsanddata.com/report-detail/tissue-diagnostics-market
Smoke Evacuation Systems Market @ https://www.reportsanddata.com/report-detail/smoke-evacuation-systems-market
http://go.iranscript.ir/index.php?url= https://www.reportsanddata.com/
http://www.vinfo.ru/away.php?url= https://www.reportsanddata.com/
http://www.banket66.ru/scripts/redirect.php?url= https://www.reportsanddata.com/
https://www.hedgeconnection.com/atlas/jump_test.php?url= https://www.reportsanddata.com/
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
